Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing

18 Nov 2009 07:00

RNS Number : 6793C
PureCircle Limited
18 November 2009
 

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

This Announcement is for information only and does not constitute an offer to sell or issue or the solicitation of an offer to buy, or subscribe for or acquire any securities, including the Placing Shares, in any jurisdiction in which such offer or solicitation is or may be unlawful.  This Announcement is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into AustraliaCanadaJapan, the Republic of South Africa, the United States or any other state or jurisdiction in which it would be unlawful to do so.  No public offer of securities of the Company is being made in the United Kingdom, the United States or elsewhere.

18 November 2009

PURECIRCLE LIMITED

("PureCircle" or the "Company")

Placing of £40 million to support accelerated growth

PureCircle (LSE: PURE), the world's leading producer of natural high intensity sweetener, Reb A, announces the placing of 20,000,000 new ordinary shares of the Company (the "Placing Shares") at a price of £2.00 each (the "Placing"), raising £40 million (approximately US$67 million) for the Company, before expenses.

Background to the Placing

Since US Food and Drug Administration "Generally Recognised as Safe" clearance for high purity Reb A to be used as a food and beverage ingredient was granted in December 2008, a range of stevia-sweetened products have been launched in the USA and performed well, securing strong sales. For example, stevia-sweetened "tabletop" products have secured 10% of the USA tabletop sweetener market. Similarly, sales of PepsiCo's SoBe Lifewater beverage flavours sweetened with Reb A, which were launched in 2009, are outperforming the category (Source: Nielsen).

With continuing pressure for the reduction of calories in food and beverages, PureCircle's discussions with both current and potential clients have led to the expectation that such clients are planning launches of stevia-sweetened products and line extensions in a wider range and larger size in 2010 and 2011.

The Company believes that ingredients in mainstream food and beverage products need to be supported by economically viable mass market pricing, scaled and secure supply and consumer demand. Accordingly, with the proceeds of the Placing, PureCircle intends to launch initiatives in all three areas.

In addition the Placing is expected to increase the liquidity in the Company's shares.

Use of proceeds

The net proceeds of the Placing will be used as follows:

US$40 million to expand and further strengthen the Group's supply chain and working capital
US$25 million in marketing and branding initiatives with a view to establishing a strong ingredient brand closely associated with the Company

The Company believes that widespread adoption of stevia by major food and beverage companies will require enhanced working capital support from PureCircle in the form of larger inventories and increased receivables resulting from higher sales volumes.  To support its global clients, PureCircle intends to hold finished goods inventories in all key sales markets.

PureCircle plans to accelerate the expansion of its production capacity, initially with a new stevia extraction facility in ParaguaySouth America. It is expected that work will start on this early in FY 2011. In addition the Company intends to invest further in proprietary leaf development and expansion as part of its global leaf diversification programme.

During 2010 PureCircle plans to invest approximately US$25 million to implement a marketing and branding campaign focused on raising consumer awareness of the benefits of stevia. The Company's aim is to integrate the marketing into its customers' launch plans. The stevia ingredient brand positioning will be aligned closely to PureCircle, thereby creating additional brand equity for the Company.

The Company's marketing plans are underpinned by the findings of a nationwide US consumer research programme commissioned by PureCircle in May 2009. This was undertaken by LaunchForce, a US consumer research firm. The research findings are being shared with PureCircle's major clients and partners. The Company believes that the findings and PureCircle's marketing plans have been well received by clients. More information about the research findings can be found by viewing the webinar recently held with the LaunchForce CEO that can be accessed from www.purecircle.com.

Following completion of the Placing, the number of shares in issue will increase from 132,723,044 to 152,723,044 (of which 44,640 are currently held by the Company in treasury (in respect of which no voting rights may be exercised)).

Details of the Placing

The Placing, which is being carried out under the existing powers of the directors, is conditional, inter alia, on completion of a placing agreement entered into between the Company, Hanson Westhouse Limited, Mirabaud Securities LLP and Liberum Capital Limited.

The Placing has not been underwritten. Application has been made for admission of the Placing Shares to trading on AIM ("Admission") and it is expected that Admission will take place at 8.00 a.m. on 20 November 2009.

Assuming that settlement and Admission occurs, the Placing will raise £40 million (approximately US$67 million) for the Company, before expenses. The funds will be used to support and accelerate PureCircle's position in the global stevia sweetener industry. 

The Placing Shares will be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares in the share capital of the Company.

Commenting on the Placing, the Company's Chairman, Paul Selway-Swift, said "We are delighted by the support shown by existing and new shareholders for the Placing, which was substantially oversubscribed. We see this as a strong vote of confidence in our growth story, underpinned by the rapidly developing global stevia market. I look forward to reporting on further progress in the future."

Commenting on the Placing, the Company's CEO, Magomet Malsagov, said "We are determined to maintain our position at the forefront of the stevia industry as its growth accelerates in 2010 and 2011. Strengthened by the funding from the Placing we are well placed to support the exciting growth plans of our clients."

Enquiries:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, Managing Director

William Mitchell, Finance Director 

+60 1 2388 8049

+44 7974 005163

Westport Communications

Alan Frame

Jeanette Bishop

+44 20 7065 2690

alan@westportcomms.com

jeanette@westportcomms.com

RFC Corporate Finance Ltd (Nomad to the Company)

Stephen Allen

+61 8 9480 2500

Hanson Westhouse Limited

Tim Feather

+44 20 7601 6100

Mirabaud Securities LLP

Rory Scott

+44 20 7321 2508

Liberum Capital Limited

Clayton Bush

+44 20 3100 2000

This announcement is for information purposes only and does not contain or constitute an offer to sell or issue or the solicitation of an offer to buy, acquire or subscribe for, securities in any jurisdiction. This announcement does not contain or constitute an offer to sell or issue or the solicitation of an offer to buy, acquire or subscribe for, securities to any person in the United States, Australia, Canada, Japan, the Republic of South Africa or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The securities referred to herein may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended (the "Securities Act") or another exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Subject to certain exceptions, the securities referred to herein may not be offered or sold in AustraliaCanadaJapan or the Republic of South Africa or to, or for the account or benefit of, any national, resident or citizen of AustraliaCanadaJapan or the Republic of South Africa. The offer and sale of the securities referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of AustraliaCanadaJapan or the Republic of South Africa. There will be no public offer of the securities in the United States.

The information in this announcement may contain forward-looking statements. Any statement other than a statement of historical fact is a forward-looking statement. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results to differ materially from those expressed or implied by any forward-looking statement. More detailed information on the potential factors that could affect the financial results of PureCircle is contained in the PureCircle's public filings and reports. PureCircle does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on any forward-looking statement, which speaks only as of the date of its issuance.

The information contained in this announcement is not for release, publication or distribution, directly or indirectly, in or into the United StatesAustraliaCanadaJapan or the Republic of South Africa.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQVLBFKFBXFBQ
Date   Source Headline
29th Oct 20097:00 amRNSProduct Launch
27th Oct 200912:35 pmRNSHolding(s) in Company
21st Oct 20097:00 amRNSPureCircle and PepsiCo to receive Scientific Excel
20th Oct 20097:00 amRNSProduct Launch
15th Oct 200910:00 amRNSTrading Statement
8th Oct 20097:00 amRNSDirector Declaration
23rd Sep 20097:00 amRNSFinal Results
8th Sep 20098:32 amRNSStatement re Approval
4th Sep 20093:00 pmRNSStatement re Shareholding
2nd Sep 200910:10 amRNSChange of Adviser
8th Jul 20097:00 amRNSTrading Update
15th Jun 20098:41 amRNSNotification of a Major Interest
27th Apr 20097:02 amRNSCompletion of Extract Plant Complex
1st Apr 20097:00 amRNSDealings in Shares
5th Mar 20099:20 amRNSDirector's Dealing
4th Mar 20097:00 amRNSHalf Yearly Report
29th Jan 20097:00 amRNSSENIOR INTERNATIONAL SALES TEAM APPOINTMENT
19th Jan 20097:00 amRNSAppointment
13th Jan 20097:00 amRNSAppointment of Head of PureCircle USA
12th Jan 20097:09 amRNSNotice of Results
6th Jan 20097:00 amRNSStrategic Global Collaboration
5th Jan 20097:00 amRNSDirector Dealings
18th Dec 20087:00 amRNSRegulatory Approval
24th Nov 20087:51 amRNSExecutive Management Appointments
10th Nov 20087:55 amRNSIssuance of Options
7th Nov 20089:51 amRNSExercise of Options
17th Oct 20083:05 pmRNSDealings in shares
15th Oct 20087:00 amRNSFinal Results
13th Oct 200812:58 pmRNSBoard Change
10th Oct 20089:44 amRNSApproval Announced
22nd Aug 20087:00 amRNSRevised Results Day
20th Aug 20088:42 amRNSBoard Appointment
31st Jul 20083:42 pmRNSMajor contract win
21st Jul 20088:45 amRNSNotice of Interim Results
2nd Jul 20088:10 amRNSRe Share Holdings
2nd Jul 20087:03 amRNSDirector's Dealings
1st Jul 20081:08 pmRNSStrategic Partnership
16th Jun 20088:34 amRNSLong Term Incentive Plan
2nd Jun 20089:27 amRNSAGM and Board appointments
2nd Jun 20087:00 amRNSDealings in Shares
20th May 20089:08 amRNSCompletion of aquisition and
9th May 20088:39 amRNSNotice of AGM
7th May 20087:00 amRNSAppointment
6th May 20088:33 amRNSKenya Joint Venture
22nd Apr 200811:19 amRNSInvestor Presentation
7th Apr 20088:37 amRNSAcquisition
1st Apr 20087:01 amRNSFinal Results
31st Mar 20089:19 amRNSNotification re: results
10th Mar 20081:16 pmRNSResults Date
28th Feb 20088:43 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.